Product Information
GLYBURID-METFORMIN 1.25-250 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0335 per EA under NDC 65862008001. Its NADAC has been published 459 times since Nov 28, 2013.
Strength
1.25; 250 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862008001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
12/18/2024
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077870On Market Since
11/14/2007
Pharmacological Classes
Price Statistics
The NADAC for GLYBURID-METFORMIN 1.25-250 MG has been published 459 times since Nov 28, 2013, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0335 per EA |
|---|---|
| All-time high | $0.0908 (May 11, 2016) |
| All-time low | $0.0335 (Oct 23, 2024) |
| 52-week high | $0.0335 |
| 52-week low | $0.0335 |
| Median price | $0.0529 |
| Average price | $0.0570 |
| Largest weekly change | +37.5% (Jun 22, 2016) |
| Weeks tracked | 459 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLYBURID-METFORMIN 1.25-250 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURID-METFORMIN 1.25-250 MG, manufactured by Aurobindo Pharma Limited, is $0.0335 per EA (NDC 65862008001), effective Dec 10, 2025.
How has the price of GLYBURID-METFORMIN 1.25-250 MG changed over time?
Over the history we have for it, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has declined 61.7%. It has been tracked across 459 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURID-METFORMIN 1.25-250 MG?
Since Nov 28, 2013, the NADAC for GLYBURID-METFORMIN 1.25-250 MG has ranged from a low of $0.0335 (Oct 23, 2024) to a high of $0.0908 (May 11, 2016), with a median of $0.0529 per EA.
Are there cheaper alternatives to GLYBURID-METFORMIN 1.25-250 MG?
2 NADAC-published products share the same active ingredient, strength, and dosage form as GLYBURID-METFORMIN 1.25-250 MG, but none are currently priced below it.
Who manufactures GLYBURID-METFORMIN 1.25-250 MG?
GLYBURID-METFORMIN 1.25-250 MG (NDC 65862008001) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification